Daniel J. George
0000-0002-0836-8542
Publication & Citation Trends
Publications
0 total
Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States? OA
Cited by 0
Semantic Scholar
Plain language summary: how long do patients with metastatic castration-resistant prostate cancer (mCRPC) live when taking abiraterone or enzalutamide in the real world? OA
Cited by 1
Semantic Scholar
Abstract 3630: First-line therapies and subjective cognitive function trajectories among international metastatic hormone-sensitive prostate cancer survivors
Cited by 0
Semantic Scholar
Abstract 4935: Disentangling the association between age and overall survival in an international cohort of patients with advanced prostate cancer
Cited by 0
Semantic Scholar
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer OA
Cited by 6
Semantic Scholar
Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer OA
Cited by 10
Semantic Scholar
Abstract 3410: Financial toxicity among patients with advanced prostate cancer in the United States
Cited by 0
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(264)
Renal cell carcinoma treatment
(132)
Prostate Cancer Diagnosis and Treatment
(90)
Cancer Genomics and Diagnostics
(83)
Radiopharmaceutical Chemistry and Applications
(74)
Affiliations
West Virginia University
Fox Chase Cancer Center
City Of Hope National Medical Center
Florida Museum of Natural History
Beth Israel Deaconess Medical Center